ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2016 American Transplant Congress

    Human Multipotent Mesenchymal Stromal Cells Improve Survival and Function of Pancreatic Islets by Cell-to-Cell Contact.

    E. Montanari,1 R. Meier,2 D. Bosco,1 R. Mahou,3 P. Morel,2 J. Seebach,4 C. Wandrey,3 C. Gonelle-Gispert,1 L. Bühler.2

    1University of Geneva, Geneva, Switzerland; 2Division of Digestive and Transplantation Surgery, University Hospitals of Geneva, Geneva, Switzerland; 3Institut d'Ingénierie Biologique et Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; 4Division of Immunology and Allergy, University Hospitals of Geneva, Geneva, Switzerland.

    Background: MSC exhibit immunomodulatory and anti-inflammatory properties. Notably, MSC were shown to preserve human islet function and to prevent cytokine-induced apoptosis. Aim: To evaluate the…
  • 2016 American Transplant Congress

    Targeting the Constitutively Active PI3K/Akt/mTOR Signaling Pathway in Epstein-Barr Virus B Cell Lymphomas.

    A. Sang, G. Ivison, C. Esquivel, S. Krams, O. Martinez.

    Division of Abdominal Transplantation, Stanford School of Medicine, Stanford, CA.

    Epstein-Barr virus (EBV) B cell lymphomas in post-transplant lymphoproliferative disorder (PTLD) is a major problem in organ transplantation. Reduction of immunosuppression sometimes result in tumor…
  • 2016 American Transplant Congress

    Short UK Dialysis Does Not Significantly Impact on Live Donor Kidney Allograft Survival.

    A. Bentall,1,2 M. Jesky,1,2 R. Borrows,1,2 R. Johnson,3 S. Ball.1,2

    1Department of Nephrology, University Hospitals Birmingham, Birmingham, United Kingdom; 2School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom; 3NHSBT, Bristol, United Kingdom.

    Background. The survival advantage of pre-emptive transplantation (Pre-empTx) in live donor kidney transplantation (LDKTx) was reported by Meier-Kreische (Kidney International, 2000). Dialysis practices differ internationally…
  • 2016 American Transplant Congress

    Reversibility of Acute Kidney Rejection According to the Banff 2013 Classification: A Retrospective Cohort Study.

    A. Poulin,1 M. Dorais,2 L. Sénécal,3 S. Colette,3 H. Cardinal.1

    1CRCHUM, Montreal, QC, Canada; 2Statsciences, Montreal, QC, Canada; 3HMR, Montreal, QC, Canada.

    Background: Vascular involvement of the allograft has classically been regarded as a poor prognostic factor in acute kidney graft rejection. Cell-mediated endarteritis often coexists with…
  • 2016 American Transplant Congress

    Subnormothermic Machine Perfusion (SNMP) with a Novel Hemoglobin-Based Oxygen Carrier (HBOC) Solution for Ex Vivo Preservation in Vascularized Composite Allotransplantation (VCA).

    S. Oksuz, R. Schweizer, M. Minervini, B. Banan, V. Gorantla, P. Fontes.

    University of Pittsburgh, Pittsburgh.

    Background: Improved preservation techniques could reduce ischemia-reperfusion injuries (IRI) and allow better matching and allocation of VCA grafts across wider distances. A novel SNMP system…
  • 2016 American Transplant Congress

    Fluctuation of Renal Function During the First Year Is Associated with Negative Impact on Long-Term Kidney Graft Survival: A Retrospective, Propensity Score-Matched Study.

    H. Choi,1 D. Joo,2,3 M. Song,4 M. Kim,2,3 Y. Kim,2,3 B. Kim.1,3

    1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; 2Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; 3The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea; 4Department of Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea.

    Background: Post-transplant renal function in the first year has been reported to predict long-term renal graft survival. The present study examined whether the fluctuation of…
  • 2016 American Transplant Congress

    The Impact of a Novel Dual Adenosine Triphosphate-Competitive mTOR Inhibitor (TORKinib) on Alloimmunity and Transplant Survival.

    D. Fantus,1 Y. Ono,1 S. Yokota,1 C. Komatsu,1 H. Turnquist,1,2 A. Thomson.1,2

    1Surgery, Thomas E Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; 2Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

    Background: Rapamycin (RAPA), an immunosuppressive agent, inhibits the mechanistic target of Rapamycin (mTOR), the kinase subunit of two mTOR- containing complexes (mTORC1 and mTORC2). While…
  • 2016 American Transplant Congress

    Outcomes of Deceased Donor Kidney Transplantation from Diabetic Donors: Does Presence of Recipient Diabetes Matter?

    J. Rogers,1 A. Farney,1 G. Orlando,1 A. Reeves-Daniel,2 A. Palanisamy,2 H. El-Hennawy,1 M. Khan,1 M. Gautreaux,1 S. Iskandar,3 W. Doares,4 S. Kaczmorski,4 R. Stratta.1

    1Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC; 2Internal Medicine, WFBMC, Winston-Salem, NC; 3Pathology, WFBMC, Winston-Salem, NC; 4Pharmacy, WFBMC, Winston-Salem, NC.

    Donor history of diabetes mellitus (DM) is a known risk factor for inferior graft survival after deceased donor kidney transplantation (DDKT) and is heavily weighted…
  • 2016 American Transplant Congress

    Clinical Outcomes of Kidney Allograft Recipients with Apolipoprotein L1 (APOL1) Risk Alleles from Living Kidney Donors.

    C. Dorr,1,2,3 A. Hart,1,2,3 D. Schladt,1 A. Muthusamy,1 R. Mannon,4 W. Oetting,2 A. Matas,2 P. Jacobson,2 A. Israni.1,2,3

    1Minneapolis Medical Research Foundation, Minneapolis; 2University of Minnesota, Minneapolis; 3Hennepin County Medical Center, Minneapolis; 4University of Alabama, Birmingham.

    Background:Apolipoprotein L1 (APOL1) alleles G1 and G2 in deceased donors are associated with poor kidney allograft survival. However, the effect of these alleles in living…
  • 2016 American Transplant Congress

    Chemokine Receptor CXCR4 Antagonist, a Novel Pathway to Prevent Chronic Allograft Nephropathy.

    Y. Xu, Q. Zhang, X. Hu.

    Department of Urology, Beijing Chaoyang Hospital, Beijing, China.

    BackgroundChronic allograft nephropathy (CAN) remains a major problem for long term graft survival and different pathways participate in its development. CXC chemokine receptor 4 (CXCR4)…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences